Bill Commons

CA AB 1320

dead

California Affordable Drug Manufacturing Act of 2020: opioid antagonists.

California · 2025-2026 Regular Session · lower

Description

Existing law, the California Affordable Drug Manufacturing Act of 2020, requires the California Health and Human Services Agency (CHHSA) or its departments to enter into partnerships, in consultation with other state departments as necessary, to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs. For purposes of implementing these provisions, existing law authorizes CHHSA and its departments, including the Department of Health Care Access and Information, to enter into exclusive or nonexclusive contracts on a bid or negotiated bases. Existing law exempts these contracts entered into by CHHSA and its departments from the review or approval of any division of the Department of General Services as well as from provisions pertaining to bidding and awarding of state contracts. This bill would prohibit a state agency from awarding a contract, pursuant to the above provisions, on a noncompetitive basis for the purchase or acquisition of an opioid antagonist, as defined, with a contractor that has entered into a multistate settlement agreement for its role in contributing to the opioid epidemic. The bill would make a contract void and unenforceable for a violation of this provision and apply those provisions retroactively to contracts entered into before January 1, 2026.

Introduced
2025-02-21
Status date
—
Latest action
2026-02-02 — From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Pattersonauthor

Committees

Not provided by source.

Action timeline

  1. 2025-02-21

    Introduced. To print.

    introduction

  2. 2025-02-22

    From printer. May be heard in committee March 24.

  3. 2025-02-24

    Read first time.

    reading-1

  4. 2025-03-13

    Referred to Com. on HEALTH.

    referral-committee

  5. 2025-04-29

    In committee: Set, first hearing. Failed passage. Reconsideration granted.

    committee-passage-unfavorable

  6. 2026-01-31

    Died pursuant to Art. IV, Sec. 10(c) of the Constitution.

    failure

  7. 2026-02-02

    From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.

    committee-passage,failure

Versions

Documents

Votes

  • Reconsideration.

    2025-04-29 · pass · 16-0

    Member-level votes (16)
    • Chen: yes
    • Flora: yes
    • Celeste Rodriguez: yes
    • Mark González: yes
    • Patterson: yes
    • Sharp-Collins: yes
    • Schiavo: yes
    • Bonta: yes
    • Aguiar-Curry: yes
    • Stefani: yes
    • Carrillo: yes
    • Krell: yes
    • Sanchez: yes
    • Arambula: yes
    • Patel: yes
    • Addis: yes

  • Do pass and be re-referred to the Committee on [Appropriations]

    2025-04-29 · fail · 4-3

    Member-level votes (16)
    • Sanchez: yes
    • Flora: yes
    • Chen: yes
    • Patterson: yes
    • Sharp-Collins: no
    • Stefani: no
    • Bonta: no
    • Celeste Rodriguez: other
    • Mark González: other
    • Schiavo: other
    • Aguiar-Curry: other
    • Carrillo: other
    • Krell: other
    • Arambula: other
    • Patel: other
    • Addis: other

Related bills

No related bills recorded for this bill.

Official source

http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202520260AB1320

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T01:34:27.960412Z

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=AB 1320. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.